A significant interest has emerged around GLP-1 Receptor medications, particularly Mounjaro, for their potential to treat type 2 diabetes and support weight reduction. These innovative therapies, initially developed for diabetes care, have demonstrated remarkable benefits in assisting individuals reach their health targets. While Wegovy are similar